13-48380039-A-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000321.3(RB1):​c.1390-14A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0546 in 1,242,656 control chromosomes in the GnomAD database, including 2,392 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 221 hom., cov: 29)
Exomes 𝑓: 0.056 ( 2171 hom. )

Consequence

RB1
NM_000321.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.649
Variant links:
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 13-48380039-A-T is Benign according to our data. Variant chr13-48380039-A-T is described in ClinVar as [Benign]. Clinvar id is 167566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0736 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RB1NM_000321.3 linkuse as main transcriptc.1390-14A>T intron_variant ENST00000267163.6 NP_000312.2 P06400A0A024RDV3
RB1NM_001407165.1 linkuse as main transcriptc.1390-14A>T intron_variant NP_001394094.1
RB1NM_001407166.1 linkuse as main transcriptc.1390-14A>T intron_variant NP_001394095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RB1ENST00000267163.6 linkuse as main transcriptc.1390-14A>T intron_variant 1 NM_000321.3 ENSP00000267163.4 P06400
RB1ENST00000650461.1 linkuse as main transcriptc.1390-14A>T intron_variant ENSP00000497193.1 A0A3B3IS71

Frequencies

GnomAD3 genomes
AF:
0.0471
AC:
6973
AN:
148040
Hom.:
221
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0120
Gnomad AMI
AF:
0.0927
Gnomad AMR
AF:
0.0458
Gnomad ASJ
AF:
0.0305
Gnomad EAS
AF:
0.000588
Gnomad SAS
AF:
0.00909
Gnomad FIN
AF:
0.0448
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0753
Gnomad OTH
AF:
0.0541
GnomAD3 exomes
AF:
0.0417
AC:
4720
AN:
113174
Hom.:
154
AF XY:
0.0410
AC XY:
2607
AN XY:
63566
show subpopulations
Gnomad AFR exome
AF:
0.00792
Gnomad AMR exome
AF:
0.0260
Gnomad ASJ exome
AF:
0.0322
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0127
Gnomad FIN exome
AF:
0.0573
Gnomad NFE exome
AF:
0.0640
Gnomad OTH exome
AF:
0.0426
GnomAD4 exome
AF:
0.0556
AC:
60894
AN:
1094532
Hom.:
2171
Cov.:
19
AF XY:
0.0549
AC XY:
30092
AN XY:
547818
show subpopulations
Gnomad4 AFR exome
AF:
0.00764
Gnomad4 AMR exome
AF:
0.0306
Gnomad4 ASJ exome
AF:
0.0351
Gnomad4 EAS exome
AF:
0.0000683
Gnomad4 SAS exome
AF:
0.0106
Gnomad4 FIN exome
AF:
0.0529
Gnomad4 NFE exome
AF:
0.0639
Gnomad4 OTH exome
AF:
0.0483
GnomAD4 genome
AF:
0.0470
AC:
6969
AN:
148124
Hom.:
221
Cov.:
29
AF XY:
0.0449
AC XY:
3238
AN XY:
72146
show subpopulations
Gnomad4 AFR
AF:
0.0120
Gnomad4 AMR
AF:
0.0457
Gnomad4 ASJ
AF:
0.0305
Gnomad4 EAS
AF:
0.000589
Gnomad4 SAS
AF:
0.00869
Gnomad4 FIN
AF:
0.0448
Gnomad4 NFE
AF:
0.0753
Gnomad4 OTH
AF:
0.0536
Alfa
AF:
0.0568
Hom.:
38
Bravo
AF:
0.0471
Asia WGS
AF:
0.0240
AC:
85
AN:
3464

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinoblastoma Benign:5
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthApr 28, 2022- -
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthOct 02, 2024- -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 04, 2016- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 13, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 24, 2016Variant summary: The RB1 c.1390-14A>T variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 1084/24708 control chromosomes (28 homozygotes) at a frequency of 0.0438724, which is approximately 1053 times the estimated maximal expected allele frequency of a pathogenic RB1 variant (0.0000417), suggesting this variant is likely a benign polymorphism. In addition, one clinical diagnostic laboratory classified this variant as benign. Taken together, this variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 22, 2023- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submittercurationSema4, Sema4Dec 09, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.2
DANN
Benign
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9535023; hg19: chr13-48954175; COSMIC: COSV57303499; COSMIC: COSV57303499; API